Filter Results:
(398)
Show Results For
- All HBS Web
(398)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
Show Results For
- All HBS Web
(398)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
- Web
Entrepreneurship - Faculty & Research
Publications Faculty William R. Kerr Lynda M. Applegate William A. Sahlman Thomas R. Eisenmann Geoffrey G. Jones Ramana Nanda Myra M. Hart Rosabeth M. Kanter Joseph B. Lassiter Howard H. Stevenson Josh Lerner View Details
- November 2012
- Supplement
Amylin Pharmaceuticals (B)
By: Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical... View Details
Keywords: Pharmaceuticals; Bristol-Myers Squibb; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Carin-Isabel Knoop. "Amylin Pharmaceuticals (B)." Harvard Business School Supplement 813-091, November 2012.
- November 2008 (Revised January 2010)
- Case
Stone Finch, Inc.: Young Division, Old Division
By: Richard G. Hamermesh and Elizabeth Collins
CEO Jim Billings wants to attract energetic, entrepreneurial talent to Stone Finch, Inc., which comprises an older division that fabricates products like piping and tanks for water and wastewater processing plants, and a much newer division that develops biochemical... View Details
Keywords: Organizational Behavior; Human Resource Management; Motivation; Business Growth; Motivation and Incentives; Leadership; Business Subsidiaries; Innovation Strategy; Resource Allocation; Organizational Structure; Organizational Culture; Retention; Operations; Recruitment; Integration; Business Growth and Maturation; Mergers and Acquisitions; Growth and Development Strategy; Manufacturing Industry
Hamermesh, Richard G., and Elizabeth Collins. "Stone Finch, Inc.: Young Division, Old Division." Harvard Business School Brief Case 083-214, November 2008. (Revised January 2010.)
- December 1998 (Revised June 1999)
- Case
STT Aerospace
By: Richard G. Hamermesh and Jeremy Dann
Experienced entrepreneur Charles Damon conducted a "roll-up" from 1987-1994 within the commercial airliner interior products industry. Damon's company, STT Aerospace, took advantage of an industry-wide recession in the early 1990s by buying when asset prices were low.... View Details
Keywords: Retention; Business Strategy; Selection and Staffing; Entrepreneurship; Financial Crisis; Growth and Development Strategy; Compensation and Benefits; Employee Stock Ownership Plan; Acquisition; Product Development; Aerospace Industry
Hamermesh, Richard G., and Jeremy Dann. "STT Aerospace." Harvard Business School Case 399-056, December 1998. (Revised June 1999.)
- Web
Research - Health Care
Faculty John Beshears Negotiation, Organizations & Markets Amitabh Chandra Technology and Operations Management Leemore S. Dafny General Management Srikant M. Datar Amy C. Edmondson Technology and Operations Management Richard View Details
- Web
Accounting & Management Awards & Honors - Faculty & Research
Intangibles, Intellectual Capital, and Sustainability by the European Institute for Advanced Studies in Management at the 2022 EIASM Interdisciplinary Conference for “Regulated Human Capital Disclosures” with Thomas Bourveau, Maliha... View Details
- Web
Business & Environment - Faculty & Research
transient investors. This result is more pronounced for firms with high growth opportunities, not controlled by a family, operating in 'sin' industries, and exhibiting commitment to IR. I find that the results are robust to the inclusion... View Details
- 28 Nov 2016
- News
One Obstacle to Curing Cancer: Patient Data Isn’t Shared
- Web
Publications - Institute For Strategy And Competitiveness
significant changes will be required. A set of six tests for physicians... June 2020 Are cost advantages from a modern Indian hospital transferable to the United States? by F. Erhun, PhD, a,b R. S. Kaplan, PhD, c V. View Details
- Web
Finance - Faculty & Research
Mortgage Convexity By: Samuel G. Hanson Most home mortgages in the United States are fixed-rate loans with an embedded prepayment option. When long-term rates decline, the effective duration of mortgage-backed securities (MBS) falls due... View Details
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Medical Devices and Supplies Industry; Biotechnology Industry; Public Administration Industry; United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- Web
Bankruptcy | Baker Library | Bloomberg Center | Harvard Business School
Skip to Main Content Lehman Brothers Collection Resources Baker Library Collections Corporate Reports Collection R. G. Dun & Co. Credit Reports HBS Cases Baker Old Class Collection Related Archival Collections Bibliography Site Credits... View Details
- Web
Leadership Transitions | Baker Library | Bloomberg Center | Harvard Business School
center, 2001. Prints & Photographs Division, Library of Congress, LC-DIG-highsm-15224. Vartan, Vartanig G. "Peterson Is Named Chief Executive by Lehman: Former Commerce Secretery to Take Ehrman's Post." The... View Details
- June 2001 (Revised November 2004)
- Case
Kingsley Management
Includes a brief overview of key challenges facing recent HBS graduates seeking funding for a business, followed by a 22-page excerpt from the Kingsley Management business plan. Describes Matthew Lieb and Chris Jones, two of the partners who developed the business plan... View Details
Keywords: Business Organization; Corporate Entrepreneurship; Business Plan; Opportunities; Investment Return; Organizational Structure
Hamermesh, Richard G. "Kingsley Management." Harvard Business School Case 801-474, June 2001. (Revised November 2004.)
- Web
Faculty & Research - Business History
Business History in Emerging Markets By: Geoffrey Jones This article describes the motivation, structure and use of the Creating Emerging Markets (CEM) oral history-based project at the Harvard Business School. The project consists of lengthy interviews with business... View Details
- Web
Business History - Faculty & Research
Soccer Competition Organizer to a Global Player in the Sports and Entertainment Industry." Harvard Business School Working Paper, No. 24-009, August 2023. More Publications Faculty Geoffrey G. Jones Tom Nicholas View Details
- January 2014
- Teaching Plan
MedImmune Ventures
By: Richard Hamermesh and Andrew Otazo
"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets. View Details
Keywords: MedImmune Ventures; NeuProtect; Corporate Venture Capital; Ron Laufer; Australia; Starfish Ventures; AstraZeneca; MEVE; Healthcare; Startup; Venture Capital; Business Startups; Health Industry; Australia; United States
Hamermesh, Richard, and Andrew Otazo. "MedImmune Ventures." Harvard Business School Teaching Plan 814-039, January 2014.
- Article
One Obstacle to Curing Cancer: Patient Data Isn't Shared
By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
- Web
Health Care - Faculty & Research
no. 10 (October 10, 2024). More Publications Faculty Michael E. Porter Regina E. Herzlinger Robert S. Kaplan Robert S. Huckman Amy C. Edmondson Richard G. Hamermesh John A.... View Details
- Web
Faculty & Researchers - Managing the Future of Work
de Chalendar. Managing Talent Pipelines in the Future of Work , Harvard Business School case, 2019. With William R. Kerr, Manjari Raman and Carl Kreitzberg. The Caring Company: How Employers Can Cut Costs And Boost Productivity By Helping... View Details